Table 1 Demographic overview of metformin and sulphonylurea therapy T2D patients
Metformin patients | Sulphonylurea patients | |
|---|---|---|
N individuals | 129,140 | 68,108 |
% males / % females | 56·1 / 43·9 | 56·3 / 43·7 |
Age at first treatment (SD) | 59·0 (12·8) | 61·1 (12.5) |
Cancer | 18·7% | 21·2% |
Cardiovascular disease | 87·2% | 88·7% |
Smokes | 51·4% | 51·6% |
Hypertensive disease | 65·0% | 67·2% |